openPR Logo
Press release

AI-based Clinical Trials Solution Provider Market Business Status, Industry Trends, Application, Types and Major Players are Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc., Phesi

02-08-2022 07:36 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: ReportsnReports

The AI-based Clinical Trials Solution Provider Market research report presents a comprehensive overview, market shares, and growth opportunities by product type, application, key manufacturers, and key regions and countries. The AI-based Clinical Trials Solution Provider Market report helps to gain insightful analyses of the market and comprehensively understand the global market and its commercial landscape.

The AI-based Clinical Trials Solution Provider Market report provides comprehensive insights into market valuations, sales, market forecasts, and market shares. In addition, this research analyzes and forecasts market size and sales. Moreover, the AI-based Clinical Trials Solution Provider Market report also provides the latest developments in the market.

Get a FREE Sample Copy of this Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=4679866

According to this study, over the next five years the AI-based Clinical Trials Solution Provider market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2026, from $ xx million in 2020.Specially this report presents the global revenue market share of key companies in AI-based Clinical Trials Solution Provider business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of AI-based Clinical Trials Solution Provider market by product type, application, key manufacturers and key regions and countries.

Segmentation by product type:
- Phase-I
- Phase-II
- Phase-III

Segmentation by Application:
- Pharmaceutical Companies
- Academia
- Others

This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
- Unlearn.AI, Inc.
- Saama Technologies
- Antidote Technologies, Inc.
- Phesi
- Deep 6 AI
- Innoplexus
- Mendel.ai
- Intelligencia
- Median Technologies
- Symphony AI
- BioAge Labs, Inc.
- AiCure, LLC
- CONSILX
- DEEP LENS AI
- Halo Health Systems
- Pharmaseal
- Ardigen
- Trials.Ai
- Koneksa Health
- Euretos
- BioSymetrics
- Google- Verily
- GNS Healthcare
- IBM Watson
- Exscientia

Check Discount For This Report: https://www.reportsnreports.com/contacts/discount.aspx?name=4679866

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global AI-based Clinical Trials Solution Provider Market Size 2021-2026
2.1.2 AI-based Clinical Trials Solution Provider Market Size CAGR by Region
2.2 AI-based Clinical Trials Solution Provider Segment by Type
2.2.1 Phase-I
2.2.2 Phase-II
2.2.3 Phase-III
2.3 AI-based Clinical Trials Solution Provider Market Size by Type
2.3.1 Global AI-based Clinical Trials Solution Provider Market Size Market Share by Type (2021-2026)
2.3.2 Global AI-based Clinical Trials Solution Provider Market Size Growth Rate by Type (2021-2026)
2.4 AI-based Clinical Trials Solution Provider Segment by Application
2.4.1 Pharmaceutical Companies
2.4.2 Academia
2.4.3 Others
2.5 AI-based Clinical Trials Solution Provider Market Size by Application
2.5.1 Global AI-based Clinical Trials Solution Provider Market Size Market Share by Application (2021-2026)
2.5.2 Global AI-based Clinical Trials Solution Provider Market Size Growth Rate by Application (2021-2026)

3 AI-based Clinical Trials Solution Provider Key Players
3.1 Date of Key Players Enter into AI-based Clinical Trials Solution Provider
3.2 Key Players AI-based Clinical Trials Solution Provider Product Offered
3.3 Key Players AI-based Clinical Trials Solution Provider Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players AI-based Clinical Trials Solution Provider Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 AI-based Clinical Trials Solution Provider by Regions
4.1 AI-based Clinical Trials Solution Provider Market Size by Regions (2021-2026)
4.2 Americas AI-based Clinical Trials Solution Provider Market Size Growth (2021-2026)
4.3 APAC AI-based Clinical Trials Solution Provider Market Size Growth (2021-2026)
4.4 Europe AI-based Clinical Trials Solution Provider Market Size Growth (2021-2026)

5 Americas
5.1 Americas AI-based Clinical Trials Solution Provider Market Size by Countries (2021-2026)
5.2 Americas AI-based Clinical Trials Solution Provider Market Size by Type (2021-2026)
5.3 Americas AI-based Clinical Trials Solution Provider Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC AI-based Clinical Trials Solution Provider Market Size by Regions
6.2 APAC AI-based Clinical Trials Solution Provider Market Size by Type (2021-2026)
6.3 APAC AI-based Clinical Trials Solution Provider Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe AI-based Clinical Trials Solution Provider by Countries (2021-2026)
7.2 Europe AI-based Clinical Trials Solution Provider Market Size by Type (2021-2026)
7.3 Europe AI-based Clinical Trials Solution Provider Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Market Drivers, Challenges and Trends
8.1 Market Drivers and Impact
8.1.1 Growing Demand from Key Regions
8.1.2 Growing Demand from Key Applications and Potential Industries
8.2 Market Challenges and Impact
8.3 Market Trends
8.4 Market Ecosystem and Roles

9 Key Investors in AI-based Clinical Trials Solution Provider
9.1 Company A
9.1.1 Company A Company Details
9.1.2 Company Description
9.1.3 Companies Invested by Company A
9.1.4 Company A Key Development and Market Layout
9.2 Company B
9.2.1 Company B Company Details
9.2.2 Company Description
9.2.3 Companies Invested by Company B
9.2.4 Company B Key Development and Market Layout
9.3 Company C
9.3.1 Company C Company Details
9.3.2 Company Description
9.3.3 Companies Invested by Company C
9.3.4 Company C Key Development and Market Layout
9.4 Company D
9.5 ……

10 Key Players Analysis

Purchase This Report: https://www.reportsnreports.com/purchase.aspx?name=4679866

Contact Us:

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com

About Us:

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI-based Clinical Trials Solution Provider Market Business Status, Industry Trends, Application, Types and Major Players are Unlearn.AI, Inc., Saama Technologies, Antidote Technologies, Inc., Phesi here

News-ID: 2547977 • Views:

More Releases from ReportsnReports

DeviceCon Series 2024 - UK Edition | MarketsandMarkets
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact! Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices. Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register MarketsandMarkets presents
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March 2024| Challenges and Factors affecting in Sterilization of medical devices and more
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, Surface and Forecast to 2025
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying

All 5 Releases


More Releases for Trials

Clinical Trials Management System Market Trends: How Decentralized Clinical Tria …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031" The global Clinical Trials Management System market is estimated to reach
Brazil Clinical Trials Market ANVISA Brazil Guidelines Brazil Clinical Trials Re …
Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering: • Brazil Clinical Trials Market Opportunity 2024 and 2030 (In US$ Billion) • Clinical Trials Regulatory Framework In Brazil • Total Number of Cancer Drugs In Clinical Trials In Brazil • Total Number Of Cancer Drugs Approved In Brazil • 400 Pages Clinical Trials Insight On All Cancer Drugs In Clinical Trials By Company, Indication and Phase • 80 Pages Clinical Insight On All Cancer Drugs Approved in Market By Company and Indication • Insight
Clinical Trials Management System Market Clinical Trials Management System Marke …
InsightAce Analytic announces the release of a market assessment report on the "Global Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type (Enterprise and Site based), By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user (Pharmaceutical and Biotechnology Firms, Medical Device Firms, CROs)- Market Outlook And Industry Analysis 2031. The global Clinical Trials Management System market is estimated to reach over USD
Revolutionizing Clinical Trials: The Evolution of eCOA, eSource, and the Clinica …
The global eCOA, eSource & clinical trials market is valued at US$ 48 billion in 2023 and is expected to reach a market size of US$ 104 billion by the end of 2033, expanding rapidly at a CAGR of 8% over the next ten years. Worldwide demand for eCOA (electronic clinical outcome assessment) solutions is predicted to rise at a CAGR of 8.2% over the forecast period. In the dynamic landscape
Virtual Clinical Trials Market - Bridging the Gap: Virtual Clinical Trials Revol …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Virtual Clinical Trials Market. Virtual Clinical Trials Market: https://www.growthplusreports.com/report/virtual-clinical-trials-market/9106 The Virtual Clinical Trials Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Clinical Trials Market: Coronavirus Pandemic Pushes Sponsors, Patients to Adopt …
Clinical trials Market: Introduction According to the report, the global clinical trials market was valued over US$ 46.7 Bn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. High prevalence and increase in incidence rate of chronic diseases, and rise in R&D activities in biotechnology & pharmaceuticals industries are anticipated to drive the global clinical trials market from 2020 to 2030. North America is projected to